Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
KABRADG •BSE
Aanjaay Industries
₹24.00-0.18 (0.74%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
23.25
Today’s high
24.69
52 week low
15.50
52 week high
35.52
Open price
24.18
Previous close
24.18
Live volume
22,882
Lower circuit
19.35
Upper circuit
29.01
Fundamentals
Market Cap
₹57Cr
ROE
16.75%
P/E Ratio(TTM)
11.57
EPS(TTM)
2.09
P/B Ratio
1.94
Dividend Yield
0.00%
Industry P/E
50.67
Book Value
12.49
Debt to Equity
0.02
Face Value
10
Financial performance
JUN '26
Revenue (Cr)
₹46.30
+30.35%
Profit (Cr)
₹2.12
+100.00%
-200204060
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +546% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +524% |
| 3Y CAGR | -45% |
About
Kabra Drugs Limited is a public company established to operate in the pharmaceutical sector by manufacturing and trading pharma-related products. The company's future development is entirely dependent on the successful commencement of its operational activities. Due to a shortage of funds, the company could not perform any business activities during the year under review. In response, several cost-cutting measures have already been undertaken by the company to prepare for future operations. The Company believes that its human capital is its biggest asset and it greatly values its human resources. As part of its strategy, the company has planned to shift its registered office from Madhya Pradesh to Tamil Nadu.;
CEO/MD
N. ARAVIND
Founded in
1989
BSE symbol
524322
Shareholding pattern
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹23,311.00 +104.00 (0.45%) | 29,793.76 | 59.85 | 15.9 | ||
PfizerPFIZER | ₹4,960.50 -29.90 (0.60%) | 22,802.96 | 31.02 | 5.43 | ||
Granules IndiaGRANULES | ₹858.15 +0.60 (0.07%) | 21,247.35 | 32.08 | 4.5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,766.00 -26.50 (0.34%) | 19,479.00 | 114.84 | 22.32 |
Livesquawk •
Kabra Drugs board approves phased entry into branded generics via strategic partners.
MD Nanjappan Aravind to initiate rollout, focusing first on South India.
2026
12
Aug
Quarterly Result
Release date
29
May
Quarterly Result
Release date
13
Feb
Quarterly Result
Release date
2025
13
Nov
Quarterly Result
Release date
14
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks